Statement from Abbott on Use of Abbott’s ARCHITECT SARS-COV-2 Antibody Test with Home Sample Collection Kits
Maidenhead, BERKSHIRE, 27th May, 2020 — We understand we live in unprecedented times, where the demand for self-sample collection solutions for testing is high, but Abbott has not currently validated our SARS-CoV-2 laboratory tests for self-sample collection procedures, such as finger stick (capilliary) blood.
The accurate tests we develop for our high-volume testing instruments are only supplied to NHS and other accredited laboratories, staffed by trained and accredited personnel. These are not home tests. The Abbott SARS-CoV-2 laboratory antibody test has currently been validated using venous blood taken by a trained professional.
Abbott is committed to bringing a range of testing options to market to help tackle the COVID-19 pandemic. We understand some accredited laboratories have completed validations using a self-sample collection procedure and they are now working with the relevant bodies to demonstrate their results and seek appropriate evaluation.
Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
The website you have requested also may not be optimized for your specific screen size.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.
The website that you have requested also may not be optimized for your screen size.
Do you wish to continue and exit this website?